This article provides an overview of solutions to address key challenges facing vaccine developers or CDMOs wishing to build their own commercial-scale mRNA production facilities.
Julie Vickers
Advertisement
Julie Vickers is a subject matter expert in Process Engineering at Jacobs.
Articles by Julie Vickers
Advertisement
Latest Updated Articles
Overcoming Engineering Challenges to Enable Commercial Scale mRNA Vaccine ManufacturingPublished: August 2nd 2022 | Updated:
Advertisement
Advertisement
